Overexpression of PTK2 has been described in a diverse assortment of human tumors, including breast cancer (Sethuraman et al., 2016), hepatocellular carcinoma, and head and neck cell carcinoma (Fan et al., 2019). The gene discussed is PTK2; the disease is breast carcinoma.